Viewing Study NCT05381935


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-25 @ 7:48 PM
Study NCT ID: NCT05381935
Status: WITHDRAWN
Last Update Posted: 2023-01-31
First Post: 2022-05-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor: Elpiscience Biopharma, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module